Varamir
Desk
News
Calendar
Pricing
Saved
Search
tickers or companies
⌘K
Start free
· no card
Sign in
LPCN compared with QNCX: revenue, margins and what each company keeps, and the suppliers and customers both name
LPCN
Lipocine Inc.
Change
Mkt cap
Revenue
Revenue
QNCX
Quince Therapeutics, Inc.
Change
Mkt cap
Revenue
Revenue
vs
Compare
LPCN
Lipocine Inc.
vs
QNCX
Quince Therapeutics, Inc.
Price
Mkt cap
Revenue
Revenue
Change
Change
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Save comparison
Copy link
Supply-chain overlap
Desk
News
Calendar
Saved
Search
Supply-chain overlap
direct ties · both sides
Sources
›
direct ties · both sides
No disclosed counterparties: LPCN, QNCX.
Role chip = supplier or customer
Source: SEC EDGAR
LPCN
Lipocine Inc.
Change
1.57
▲
+8.86%
· post 1.44
Mkt cap
$15.9M
Revenue
$2M
Q3 FY26
Revenue
$2M
FY25
QNCX
Quince Therapeutics, Inc.
Change
28.50
▼
−10.01%
· post 28.50
Closed
Nov 5 '26
Mkt cap
$29.8M
Revenue
—
Revenue
—
vs
Compare
Closed
Nov 5 '26
LPCN
Lipocine Inc.
vs
QNCX
Quince Therapeutics, Inc.
1.57
▲
+8.86%
post 1.44
Price
28.50
▼
−10.01%
post 28.50
$15.9M
Mkt cap
$29.8M
Q3 FY26
$2M
Revenue
—
FY25
$2M
Revenue
—
Change
Change
LPCN
1.57
▲
+8.86%
vs
QNCX
28.50
▼
−10.01%
Closed
Nov 5 '26